NexImmune Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers (NCT05582590) | NexImmune Inc. | 2025-03-31 |
| Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma (NCT04505813) | NexImmune Inc. | 2020-08-17 |
| Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT (NCT04284228) | NexImmune Inc. | 2020-02-20 |
Track NexImmune Inc. automatically
Every clearance here is in the API, with alerts when new ones post.